Emerging options for the treatment of melanoma – focus on ipilimumab

por Roddie, Claire, Peggs, Karl S
Publicado 2014

Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation

por Shafat, Manar S., Mehra, Vedika, Peggs, Karl S., Roddie, Claire
Publicado 2020

Tumour heterogeneity and immune-modulation

por Jamal-Hanjani, Mariam, Thanopoulou, Eirini, Peggs, Karl S, Quezada, Sergio A, Swanton, Charles
Publicado 2013

Lymphocyte morphology in a patient receiving CD19 chimeric antigen receptor T‐cell therapy for mantle cell lymphoma

por Marzolini, Maria A. V., Neill, Lorna, O'Reilly, Maeve, Peggs, Karl S., Roddie, Claire
Publicado 2021

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

por Peggs, Karl S., Quezada, Sergio A., Chambers, Cynthia A., Korman, Alan J., Allison, James P.
Publicado 2009

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

por Quezada, Sergio A., Peggs, Karl S., Simpson, Tyler R., Shen, Yuelei, Littman, Dan R., Allison, James P.
Publicado 2008

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

por Quezada, Sergio A., Simpson, Tyler R., Peggs, Karl S., Merghoub, Taha, Vider, Jelena, Fan, Xiaozhou, Blasberg, Ronald, Yagita, Hideo, Muranski, Pawel, Antony, Paul A., Restifo, Nicholas P., Allison, James P.
Publicado 2010

Diagnosis of Neuroinvasive Astrovirus Infection in an Immunocompromised Adult With Encephalitis by Unbiased Next-Generation Sequencing

por Naccache, Samia N., Peggs, Karl S., Mattes, Frank M., Phadke, Rahul, Garson, Jeremy A., Grant, Paul, Samayoa, Erik, Federman, Scot, Miller, Steve, Lunn, Michael P., Gant, Vanya, Chiu, Charles Y.
Publicado 2015

Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional...

por Miller, Paul D E, Forster, Alice S, de Silva, Thushan I, Leonard, Hayley, Anthias, Chloe, Mayhew, Michaela, Klammer, Matthias, Paskar, Susan, Hurst, Erin, Peggs, Karl, Madrigal, Alejandro, A Snowden, John
Publicado 2018

Comparison of graft versus host disease with three different alemtuzumab schedules in unrelated donor fludarabine and melphalan allografts

por Green, Kile, Pearce, Kim, Sellar, Rob S, Jardine, Laura, Nicolson, Phillip LR, Nagra, Sandeep, Bigley, Venetia, Jackson, Graham, Dickinson, Anne M, Thomson, Kirsty, Mackinnon, Stephen, Craddock, Charles, Peggs, Karl S, Collin, Matthew
Publicado 2017

Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning

por Townsend, William M, Holroyd, Ailsa, Pearce, Rachel, Mackinnon, Stephen, Naik, Prakesh, Goldstone, Anthony H, Linch, David C, Peggs, Karl S, Thomson, Kirsty J, Singer, Mervyn, Howell, David C J, Morris, Emma C
Publicado 2013

AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival

por Mehra, Vedika, Agliardi, Giulia, Dias Alves Pinto, Juliana, Shafat, Manar S, Garai, Amaia Cadinanos, Green, Louisa, Hotblack, Alastair, Arce Vargas, Fred, Peggs, Karl S, van der Waart, Anniek B, Dolstra, Harry, Pule, Martin A, Roddie, Claire
Publicado 2023

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

por Simpson, Tyler R., Li, Fubin, Montalvo-Ortiz, Welby, Sepulveda, Manuel A., Bergerhoff, Katharina, Arce, Frederick, Roddie, Claire, Henry, Jake Y., Yagita, Hideo, Wolchok, Jedd D., Peggs, Karl S., Ravetch, Jeffrey V., Allison, James P., Quezada, Sergio A.
Publicado 2013

Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function

por Cuadrado, Maria M., Szydlo, Richard M., Watts, Mike, Patel, Nishil, Renshaw, Hanna, Dorman, Jude, Lowdell, Mark, Ings, Stuart, Anthias, Chloe, Madrigal, Alejandro, Mackinnon, Stephen, Kottaridis, Panagiotis, Carpenter, Ben, Hough, Rachael, Morris, Emma, Thomson, Kirsty, Peggs, Karl S., Chakraverty, Ronjon
Publicado 2019

Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas

por Gerlinger, Marco, Quezada, Sergio A, Peggs, Karl S, Furness, Andrew JS, Fisher, Rosalie, Marafioti, Teresa, Shende, Vishvesh H, McGranahan, Nicholas, Rowan, Andrew J, Hazell, Steven, Hamm, David, Robins, Harlan S, Pickering, Lisa, Gore, Martin, Nicol, David L, Larkin, James, Swanton, Charles
Publicado 2013

Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti‐CD19 CAR‐T therapy: a case report

por Mackenzie, Strachan, Shafat, Manar, Roddy, Harriet, Hyare, Harpreet, Neill, Lorna, Marzolini, Maria A. V., Gilhooley, Michael, Marafioti, Teresa, Kara, Eleanna, Sanchez, Emilie, Rees, Jeremy, Lynch, David S., Thomson, Kirsty, Ardeshna, Kirit M., Laurence, Arian, Peggs, Karl S., O'Reilly, Maeve, Roddie, Claire
Publicado 2021

Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors

por Vesely, Clare, Wong, Yien Ning Sophia, Childs, Alexa, Akarca, Ayse U., Dhami, Pawan, Vaikkinen, Heli, Conde, Lucia, Herrero, Javier, Ogunbiyi, Olagunju, Gander, Amir, Luong, Tu Vinh, Thirlwell, Chrissie, Caplin, Martyn, Toumpanakis, Christos, Peggs, Karl, Quezada, Sergio A., Marafioti, Teresa, Meyer, Tim
Publicado 2022

A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation

por Paul, Dirk S., Jones, Allison, Sellar, Rob S., Mayor, Neema P., Feber, Andrew, Webster, Amy P., Afonso, Neuza, Sergeant, Ruhena, Szydlo, Richard M., Apperley, Jane F., Widschwendter, Martin, Mackinnon, Stephen, Marsh, Steven G. E., Madrigal, J. Alejandro, Rakyan, Vardhman K., Peggs, Karl S., Beck, Stephan
Publicado 2015

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant

por Ariza-Heredia, Ella J, Winston, Drew J, Rowley, Scott D, Mullane, Kathleen, Chandrasekar, Pranatharthi, Hari, Parameswaran, Avery, Robin K, Peggs, Karl S, Kumar, Deepali, Nath, Rajneesh, Ljungman, Per, Mossad, Sherif B, El Haddad, Lynn, Shah, Dimpy P, Jiang, Ying, Khawaja, Fareed, Dadwal, Sanjeet, Blanchard, Ted, Chemaly, Roy F
Publicado 2023

Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting

por Marzolini, Maria A. V., Mehra, Varun, Thomson, Kirsty J., Tholouli, Eleni, Bloor, Adrian J. C., Parker, Anne, Lovell, Richard, Orchard, Kim, Publicover, Amy, Nicholson, Emma, Snowden, John A., Byrne, Jennifer, Khan, Anjum, Gilleece, Maria H., Errico, Gerardo, Lozano, Sara, Hurst, Erin, Duncan, Nick, Pirrie, Jennifer, Crea, Philip, Carpenter, Ben, Pagliuca, Antonio, Peggs, Karl S.
Publicado 2021